6/5/2023British Businesses in China: Conditionally Optimistic for 2023 (China ...

6/1/2023The U.S.-Chinese Economic Relationship Is Changing—But Not Vanishing ...

6/1/2023NH's DB6: China's Consumer Healthcare Market Underperformed in 2022

6/1/2023NH's DB6: Top Ten Chinese CHC Brands in 2021

6/1/2023NH's DB6: Chinese Consumer Healthcare Market Forecast 2027/2032

6/1/2023Edelman Report Finds Chinese Trusting Pharma the Most

5/31/2023Sanofi Ups Bet on China with Plan to Enhance Manufacturing and Researc...

5/29/2023A Share-Listed Chinese MedPharm Cos Report Performance in 2022 with Ov...

5/29/2023Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2022

5/22/2023SMEI: Chinese Terminal Drug Market Growth Slowed to 1.1% in 2022 (Upda...

5/19/2023An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...

5/18/2023Chinese A Shared-listed Pharma Companies Report Mixed Q1/2023 Performa...

5/16/2023China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...

5/5/2023Reshoring and Nearshoring – Is China Still Relevant? (TMD)

5/4/2023AstraZeneca Places Bet on COPD as COVID Vaccine Sales Fade

5/3/2023Getting Novel Drugs to China Through Special Zones (thepharmaletter)

4/28/2023AstraZeneca Eyes More China Deals After Signing Three Licensing Deals

4/26/2023Why Rising Demand for Healthcare Is Creating Investment Opportunities ...

4/21/2023AstraZeneca Oncology R&D Head On China Biotech Innovation - Looking Ag...

4/21/2023NMPA Issues the 2022 Drug Regulatory Statistics Annual Report

4/12/2023Yicai: Most Chinese Regions Eye Healthcare Industry Upgrades

4/12/2023Outlook of China's Health Systems (Informa)

4/10/2023FT: Astellas to Stay Put in China Despite Growing Geopolitical Tension

4/8/2023South Korean Biotech Companies Seek to Diversify from China as US Tens...

4/8/2023EU-China Relations – Trade, Investment, and Recent Developments (Chin...

4/1/2023China Further Intensifies Healthcare Cost Containment and Price Contro...

3/29/2023Investing in China's Healthcare Sector (China Briefing)

3/15/2023Deloitte: 2023 China LSHC Investment and M&A Market Outlook

3/9/2023PhIIC: Chinese Retail Pharmacy Sales Fell Sharply in 2022 Despite Rebo...

2/24/2023SMEI: Chinese Pharma Revenues Down 1.6% Last Year But Expected to Rebo...

Page:4/35 Total number of articles:1050: [First][<<] [2] [3] [4] [5] [6] [>>] [End]